Navarra, Pierluigi
 Distribuzione geografica
Continente #
EU - Europa 7.851
NA - Nord America 7.609
AS - Asia 4.465
SA - Sud America 1.102
AF - Africa 100
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.156
Nazione #
US - Stati Uniti d'America 7.418
DE - Germania 2.484
SG - Singapore 2.126
CN - Cina 1.248
IT - Italia 1.225
PL - Polonia 1.152
BR - Brasile 923
SE - Svezia 912
UA - Ucraina 479
FR - Francia 405
GB - Regno Unito 337
IE - Irlanda 253
VN - Vietnam 227
IN - India 222
FI - Finlandia 167
ID - Indonesia 162
RU - Federazione Russa 129
CA - Canada 85
TR - Turchia 83
AR - Argentina 70
HK - Hong Kong 66
MX - Messico 66
NL - Olanda 66
JP - Giappone 55
ES - Italia 52
BD - Bangladesh 46
BE - Belgio 45
IQ - Iraq 41
ZA - Sudafrica 37
AT - Austria 29
EC - Ecuador 29
CL - Cile 24
KR - Corea 22
AU - Australia 19
IR - Iran 19
CH - Svizzera 18
SA - Arabia Saudita 17
VE - Venezuela 17
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
LT - Lituania 15
MA - Marocco 15
AZ - Azerbaigian 13
KE - Kenya 13
AE - Emirati Arabi Uniti 11
IL - Israele 11
KZ - Kazakistan 11
CO - Colombia 10
PE - Perù 10
TT - Trinidad e Tobago 10
EG - Egitto 8
GR - Grecia 8
BG - Bulgaria 7
BO - Bolivia 7
HU - Ungheria 7
LV - Lettonia 7
MY - Malesia 7
UY - Uruguay 7
CI - Costa d'Avorio 6
JM - Giamaica 6
OM - Oman 6
PK - Pakistan 6
PT - Portogallo 6
RO - Romania 6
DO - Repubblica Dominicana 5
HN - Honduras 5
JO - Giordania 5
LB - Libano 5
NP - Nepal 5
PA - Panama 5
PH - Filippine 5
CR - Costa Rica 4
GE - Georgia 4
NO - Norvegia 4
PY - Paraguay 4
TN - Tunisia 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
MN - Mongolia 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
EU - Europa 2
GH - Ghana 2
IS - Islanda 2
MD - Moldavia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
Totale 21.134
Città #
Chandler 1.208
Warsaw 1.052
Singapore 893
Ashburn 787
Jacksonville 319
San Mateo 274
Dublin 253
Beijing 236
Wilmington 230
Fairfield 229
Verona 227
New York 216
Nanjing 201
Milan 199
Houston 196
Ann Arbor 182
Rome 167
Chicago 166
Los Angeles 164
Woodbridge 157
Jakarta 151
Nürnberg 144
Cattolica 142
Seattle 141
Bremen 127
Munich 125
Hefei 113
Dearborn 110
Dallas 98
Boston 94
São Paulo 91
Cambridge 90
Kraków 88
Lawrence 85
Moscow 85
Nanchang 80
Buffalo 79
Marseille 77
Ho Chi Minh City 76
Frankfurt am Main 69
Redwood City 66
Hong Kong 64
Princeton 56
The Dalles 53
Izmir 48
Hanoi 47
Brussels 45
Helsinki 44
Salt Lake City 44
Lancaster 43
London 43
Mountain View 43
Tokyo 39
Kunming 36
Santa Clara 36
Hangzhou 35
Boardman 33
North Bergen 33
Shenyang 33
University Park 32
Phoenix 31
Jiaxing 30
Nuremberg 30
Tianjin 30
Leawood 29
Fremont 28
Düsseldorf 27
Hyderabad 27
Pune 27
Rio de Janeiro 26
Toronto 26
Brooklyn 25
Denver 25
Chennai 24
Atlanta 23
Belo Horizonte 23
Changsha 23
Hebei 23
Kent 23
Philadelphia 23
Guangzhou 22
Stockholm 22
Montreal 21
Redmond 21
Shanghai 21
Brasília 20
Falkenstein 19
Lappeenranta 19
Norwalk 19
Zhengzhou 19
Johannesburg 18
San Diego 18
Seoul 18
Tampa 18
Orem 17
Salvador 17
Elk Grove Village 16
Lauterbourg 16
Paris 16
Porto Alegre 16
Totale 11.190
Nome #
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 413
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 412
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 390
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 387
mTOR kinase: a possible pharmacological target in the management of chronic pain 381
The human microglial HMC3 cell line: where do we stand? A systematic literature review 373
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 358
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 351
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 342
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 340
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 301
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 255
Effects of remifentanil on human C20 microglial pro-inflammatory activation 230
The role of small intestinal bacterial overgrowth in Parkinson's disease 229
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 213
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 212
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 211
Full HTA di Emicizumab 211
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 190
Antiretrovirals inhibit arginase in human microglia 183
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 181
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 177
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 176
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 175
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 174
Antiproliferative and Antimigratory Effects of mTOR Inhibitors in Paediatric Low-grade Gliomas Models. A Comparison between Rapamycin and Sapanisertib 172
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 166
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 164
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 163
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 162
Variability of raltegravir plasma levels in the clinical setting 160
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 158
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 157
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 155
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 154
Antiretrovirals inhibit arginase in human microglia 154
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 153
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 152
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 152
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 151
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 150
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 148
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 146
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 145
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 145
Pro-inflammatory activation of a new immortalized human microglia cell line 145
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 144
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 143
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 142
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 142
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 141
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 140
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 136
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 135
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 133
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 133
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 132
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 131
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 131
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 130
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 129
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 128
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 127
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 127
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 127
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 127
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 127
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 125
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 125
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 124
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 124
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 123
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 122
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 122
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 120
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 120
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 120
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 119
Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer 119
Local Investigators Significantly Overestimate Overall Response Rates Compared to Blinded Independent Central Reviews in Phase 2 Oncology Trials 119
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 118
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 117
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 117
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 116
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 116
Exploiting microglial functions for the treatment of glioblastoma 114
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 114
Remifentanil-induced hyperalgesia in healthy volunteers: a systematic review and meta-analysis of randomized controlled trials 112
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 112
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 111
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 110
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 110
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 109
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 109
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 108
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 108
Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. 107
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 106
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 106
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB 105
Totale 16.729
Categoria #
all - tutte 79.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021864 0 0 0 0 0 74 217 39 188 99 206 41
2021/20221.722 151 112 26 102 121 65 42 237 72 96 431 267
2022/20233.125 360 455 242 523 244 370 115 271 349 48 93 55
2023/20241.641 90 400 66 153 84 219 119 55 30 58 182 185
2024/20253.394 77 88 226 121 260 137 60 179 548 302 923 473
2025/20264.217 1.058 248 504 911 1.300 196 0 0 0 0 0 0
Totale 21.365